Field of Interest: Dermatology

Apremilast approval expanded to include plaque psoriasis

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology
Type: News Item

Closing large dermal defects much like a Victorian corset

EDINBURGH – Barbed absorbable sutures are a useful new tool to facilitate dermal closure of facial and nonfacial defects following tumor resection. “These are not the bad old sutures that you might...

Field of Interest: Dermatology
Type: News Item

Senate OKs sunscreen bill

The Senate unanimously approved a bill designed to speed up Food and Drug Administration approval of sunscreen ingredients, adding to the likelihood that the legislation will become law. The full...

Field of Interest: Dermatology
Type: News Item

Mobile apps get skin in the sun protection game

EDINBURGH – Mobile phone apps that provide real-time, personalized sun risk and protection information are gaining ground in the fight against skin cancer. The <link...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness